A computer decision model suggests that for patients with a history of bleeding within the brain, the risk of recurrence associated with statin treatment may outweigh the benefit of the drug in preventing cardiovascular disease, according to a report posted online today that will appear in the May print issue of Archives of Neurology.

Statin risks may outweigh benefits for patients with a history of brain hemorrhage

10/Jan/2011

A computer decision model suggests that for patients with a history of bleeding within the brain, the risk of recurrence associated with statin treatment may outweigh the benefit of the drug in preventing cardiovascular disease, according to a report posted online today that will appear in the May print issue of Archives of Neurology.

Link to full journal release on study led by MGH physicians Steven Greenberg and Brandon Westover.

Media Contacts: Mike Morrison, mdmorrison@partners.org, 617-724-6425